Abstract
Acinetobacter baumannii is a challenging pathogen due to antimicrobial resistance and biofilm development. The role of iron in bacterial physiology has prompted the evaluation of iron-modulation as an antimicrobial strategy. The non-reducible iron analog gallium(III) nitrate, Ga(NO3)3, has been shown to inhibit A. baumannii planktonic growth; however, utilization of heme-iron by clinical isolates has been associated with development of tolerance. These observations prompted the evaluation of iron-heme sources on planktonic and biofilm growth, as well as antimicrobial activities of gallium meso-and protoporphyrin IX (Ga-MPIX and Ga-PPIX), metal heme derivatives against planktonic and biofilm bacteria of multidrug-resistant (MDR) clinical isolates of A. baumannii in vitro. Ga(NO3)3 was moderately effective at reducing planktonic bacteria (64 to 128 _M) with little activity against biofilms (≥512 μM). In contrast, Ga-MPIX and Ga-PPIX were highly active against planktonic bacteria (0.25 to 8 μM). Cytotoxic effects in human fibroblasts were observed following exposure to concentrations exceeding 128 μM of Ga-MPIX and Ga-PPIX.We observed that the gallium metal heme conjugates were more active against planktonic and biofilm bacteria, possibly due to utilization of heme-iron as demonstrated by the enhanced effects on bacterial growth and biofilm formation.
Original language | English (US) |
---|---|
Article number | 16 |
Journal | Pharmaceuticals |
Volume | 9 |
Issue number | 1 |
DOIs | |
State | Published - Mar 17 2016 |
Externally published | Yes |
Keywords
- Acinetobacter baumannii
- Biofilm
- Gallium mesoporphyrin IX
- Gallium protoporphyrin IX
- Multidrug-resistant
ASJC Scopus subject areas
- Drug Discovery
- Molecular Medicine
- Pharmaceutical Science